sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
30-Aug-2016 15:02
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 1-25 out of 1330.

1 | 2 | 3 | 4 | 5 > >>

Public Release: 30-Aug-2016
ESC Congress 2016
Caution urged in the use of blood pressure lowering treatment for heart disease patients
Caution has been urged in the use of blood pressure lowering treatment for heart disease patients after a study in more than 22 000 patients with coronary artery disease found that too low blood pressure was associated with worse outcomes. The analysis from the CLARIFY registry is presented today at ESC Congress and published in The Lancet.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 30-Aug-2016
Family Medicine and Community Health
Global reach of Family Medicine and Community Health
The global reach of family medicine and community health is the theme of the new issue of Family Medicine and Community Health, an international medical journal with editorial offices in China and the US.
Chinese General Practice Press

Contact: Virginia O'Brien
vobrien@compuscript.com
353-614-72743
Family Medicine and Community Health

Public Release: 30-Aug-2016
ESC Congress 2016
A rapid and effective antidote for anticoagulant bleeds
A specially designed antidote to reverse acute, potentially life-threatening anticoagulant-related bleeding worked quickly, and was well-tolerated according to interim results of the ongoing ANNEXA-4 study.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 30-Aug-2016
ESC Congress 2016
ENSURE-AF trial edoxoban: A new anticoagulant option before cardioversion
Patients with atrial fibrillation who need anticoagulation before undergoing electrical correction of their abnormal heartbeat (cardioversion) may benefit from treatment with edoxoban -- a non-vitamin K antagonist oral anticoagulant, according to results of the ENSURE-AF trial.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 30-Aug-2016
ESC Congress 2016
REVERSE II trial decision rule helps identify women who can safely discontinue anticoagulants
A clinical decision rule that can be applied to women after a first, unprovoked venous thromboembolism was able to identify those with a low-risk of recurrence who could safely discontinue anticoagulant therapy, researchers reported at ESC Congress 2016.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 30-Aug-2016
ESC Congress 2016
YEARS algorithm in suspected pulmonary embolism: Towards a reduced rate of pulmonary imaging
Patients with suspected pulmonary embolism often undergo computed tomography pulmonary angiography to confirm or exclude the diagnosis.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 30-Aug-2016
ESC Congress 2016
European Heart Journal
Intravascular imaging identifies some heart attack patients who can forgo stenting
More than one-quarter of heart attack patients who are normally treated with stents to reopen their blocked arteries might be able to forgo this procedure and receive anti-thrombotic medications only, according to results of a pilot study.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 30-Aug-2016
ESC Congress 2016
European Heart Journal
First randomized trial compares stenting techniques for coronary bifurcation
Coronary bifurcations -- a type of coronary artery narrowing -- are best treated with a technique known as culotte stenting, as opposed to T-and-protrusion stenting, when there is need for a side-branch stent according to results of the BBK II (Bifurcations Bad Krozingen) trial.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 30-Aug-2016
ESC Congress 2016
BASKET-SAVAGE trial: Drug-eluting stents more benefit in saphenous vein grafts
Drug-eluting stents had a clear advantage over bare metal stents in patients undergoing revascularization of saphenous (leg) vein grafts, results of the BASKET-SAVAGE trial show.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 30-Aug-2016
ESC Congress 2016
Less efficacy than expected in largest drug-eluting stent trial
New generation drug-eluting stents did not outshine contemporary bare metal stents as they were expected to, in a surprise finding of the largest randomized stent trial to date.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 30-Aug-2016
ESC Congress 2016
PRAGUE-18 trial: Prasugrel and ticagrelor: Equally safe and effective in STEMI
The antiplatelet drugs prasugrel and ticagrelor had similar safety and efficacy among patients with acute myocardial infarction and ST segment elevations (STEMI), according to results of PRAGUE-18, the first randomized, head-to-head comparison of the drugs.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 29-Aug-2016
American Journal of Tropical Medicine and Hygiene
Female mosquitoes can transmit Zika virus to their eggs and offspring
New research from The University of Texas Medical Branch in Galveston has shown that female Aedes aegypti mosquitoes can pass the Zika virus to their eggs and offspring. The recent Zika virus outbreak in Florida has dramatically increased efforts to remove A. aegypti mosquitoes. The new findings highlight the importance of including larvicide in the efforts to curb the spread of the Zika virus. The findings can be found in the American Journal of Tropical Medicine and Hygiene.

Contact: Donna Ramirez
donna.ramirez@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston

Public Release: 29-Aug-2016
Journal of Neuroscience
Vesicles that trap amyloid appear to also contribute to Alzheimer's
Vesicles, fluid-filled sacs that brain cells make to trap amyloid, a hallmark of Alzheimer's, appear to also contribute to the disease, scientists report.
National Institutes of Health

Contact: Toni Baker
tbaker@augusta.edu
706-721-4421
Medical College of Georgia at Augusta University

Public Release: 29-Aug-2016
American Journal of Tropical Medicine and Hygiene
Study may explain why people with type O blood more likely to die of cholera
People with blood type O often get more severely ill from cholera than people of other blood types. Researchers from Washington University School of Medicine in St. Louis have found that cholera toxin activates a key signaling molecule more strongly in people with blood type O than type A, possibly leading to more severe symptoms.
US Department of Veterans Affairs, NIH/National Institute of Allergy and Infectious Diseases, NIH/National Center for Advancing Translational Sciences, Digestive Diseases Research Core Center at Washington University School of Medicine

Contact: Judy Martin Finch
martinju@wustl.edu
314-286-0105
Washington University School of Medicine

Public Release: 29-Aug-2016
Nature Medicine
NIH collaboration helps advance potential Zika treatments
Researchers at the National Center for Advancing Translational Sciences recently identified compounds that potentially can be used to inhibit Zika virus replication and reduce its ability to kill brain cells.
National Institutes of Health

Contact: Geoff Spencer
spencerg@mail.nih.gov
301-435-0888
NIH/National Center for Advancing Translational Sciences (NCATS)

Public Release: 29-Aug-2016
ESC Congress 2016
PACIFIC TRIAL: First head-to-head comparison of noninvasive coronary artery imaging
For patients presenting for the first time with suspected coronary artery disease clinicians have had a number of noninvasive diagnostic tests to choose from, but little evidence for which is best.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 29-Aug-2016
ESC Congress 2016
Circulation: Journal of the American Heart Association
DOCTORS trial: Invasive imaging sheds more light on percutaneous coronary intervention
An invasive imaging technique called optical coherence tomography can visualize the coronary arteries in patients undergoing percutaneous coronary intervention (PCI) and lead to better outcomes compared to standard angiography-guided PCI, according to new findings reported here.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 29-Aug-2016
ESC Congress 2016
The CONSERVE trial: Noninvasive imaging can guide more selective invasive coronary angiography
In stable symptomatic patients with suspected coronary artery disease, a strategy of using noninvasive computed tomography to guide the selective use of invasive coronary angiography was safe, and less expensive compared with direct invasive angiography.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 29-Aug-2016
ESC Congress 2016
CE-MARC 2: Pointing the way to fewer invasive angiograms
Initial investigation of patients with suspected coronary heart disease using functional imaging -- rather than guideline-directed care -- resulted in significantly less unnecessary angiography, according to results of the CE-MARC 2 trial.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 29-Aug-2016
ESC Congress 2016
AMERICA: No benefit to detecting and treating extra-coronary lesions
In patients with high-risk coronary artery disease, an active strategy of detecting and treating asymptomatic multisite artery disease combined with intensive medical therapy did not improve two-year outcomes compared to a more traditional approach of managing only symptomatic coronary and extra-coronary lesions, new research shows.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 29-Aug-2016
ESC Congress 2016
European Heart Journal: Acute Cardiovascular Care
First European standards for management of heart attack patients launched today
The first European standards for the management of heart attack patients are launched today by the European Society of Cardiology-Acute Cardiac Care Association. The quality indicators for acute myocardial infarction are published in European Heart Journal: Acute Cardiovascular Care, ACCA's official journal, and presented at ESC Congress together with the results of the inaugural implementation.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 29-Aug-2016
ESC Congress 2016
Lipoprotein apheresis: A new approach to refractory angina?
Initial investigation of patients with suspected coronary heart disease using functional imaging -- rather than guideline-directed care -- resulted in significantly less unnecessary angiography, according to results of the CE-MARC 2 trial.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 29-Aug-2016
ESC Congress 2016
ODYSSEY ESCAPE: Alirocumab cuts apheresis rates in familial hypercholesterolemia
Patients who have heterozygous familial hypercholesterolemia, a condition that causes abnormally raised low-density lipoprotein cholesterol levels and premature cardiovascular disease, can significantly reduce or even eliminate their need for expensive and time-consuming apheresis treatments with the PCSK9 inhibitor alirocumab.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 29-Aug-2016
ESC Congress 2016
OPTICARE trial: Enhanced cardiac rehab programs help heart attack patients
Enhanced cardiac rehabilitation programs that include a year of group or personal lifestyle and fitness coaching did not improve cardiovascular risk scores more than a standard three-month program in patients recovering from a heart attack.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 29-Aug-2016
ESC Congress 2016
'Multiplicative' benefit of cholesterol and blood pressure-lowering on cardiovascular risk
Long-term exposure to the combination of even modestly lower LDL cholesterol and systolic blood pressure has the potential to 'dramatically reduce' a person's lifetime risk of cardiovascular disease, according to new findings reported at ESC Congress 2016.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Showing releases 1-25 out of 1330.

1 | 2 | 3 | 4 | 5 > >>